Officer received an award of 12K REGN derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Dec 5, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Dec 9, 2025
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001663758-25-000007
- Filed / recorded
Dec 9, 2025, 9:10 PM UTCAdded to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerREGENERON PHARMACEUTICALS, INC. Reporting personMarion Mccourt Officer titleEVP Commercial SecurityNon-Qualified Stock Option (right to buy) TableDerivative (Table II) Transaction dateDec 5, 2025 Acquired / disposedAcquired (A) Footnotes from the filing
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.